VANCOUVER, British Columbia, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Tuesday, November 8, 2011 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss its third quarter operating results and a summary of corporate highlights.
